What is NDC 62332-799?

62332-799 is the product NDC for carbidopa, levodopa and entacapone, Carbidopa 37.5 mg/1 + 2 more ingredients tablet, film coated, listed with the FDA by Alembic Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

What is the active ingredient?

Carbidopa, Levodopa, Entacapone.

Alembic Pharmaceuticals Inc., NDC labeler code 62332. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for carbidopa, levodopa and entacapone?

29 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

carbidopa, levodopa and entacapone NDC 62332-799

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-799Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0799Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62332-799-31	6233207993162332079931	100 TABLET, FILM COATED in 1 BOTTLE (62332-799-31)Marketed from Feb 12, 2026
62332-799-91	6233207999162332079991	1000 TABLET, FILM COATED in 1 BOTTLE (62332-799-91)Marketed from Feb 12, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): carbidopa, levodopa and entacapone
Generic name (nonproprietary): carbidopa, levodopa and entacapone
Active ingredients: Carbidopa — 37.5 mg/1Levodopa — 150 mg/1Entacapone — 200 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Alembic Pharmaceuticals Inc.NDC labeler code 62332
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218535
Marketing start: Feb 12, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Aromatic (Chemical structure)Catechol O-Methyltransferase Inhibitors (Mechanism)
Identifiers: Product ID 62332-799_22161ca2-39cb-4c32-82f2-838ef88e6fc2SPL ID 22161ca2-39cb-4c32-82f2-838ef88e6fc2SPL set ID 9d4e886e-edec-471d-b619-bf4828a6b7ceRxCUI 403850, 403851, 403852, 730988, 810083, 810090UNII MNX7R8C5VO, 4975G9NM6T, 46627O600JUPC 0362332797318, 0362332799312, 0362332800315, 0362332798315, 0362332796311, 0362332795314
Pharmacologic class: Aromatic Amino Acid; Catechol-O-Methyltransferase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332079931 followed by a unit qualifier and the quantity

Package 62332-0799-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 31, 2026.

Indications (excerpt from the label)

Carbidopa, levodopa and entacapone tablets are indicated for the treatment of Parkinson’s disease. Carbidopa, levodopa and entacapone tablets can be used: • To substitute (with equivalent strengths of each of the three components) carbidopa/levodopa and entacapone previously administered as individual products. • To replace carbidopa/levodopa therapy (without entacapone) when patients experience the signs and symptoms of end-of-dose “wearing-off” and when they have been taking a total daily dose of levodopa of 600 mg or less and have not been experiencing dyskinesias. Carbidopa, levodopa and entacapone tablets, a combination drug consisting of levodopa (aromatic amino acid), carbidopa (aroma…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62332-799

What is NDC 62332-799?: 62332-799 is the product NDC for carbidopa, levodopa and entacapone, Carbidopa 37.5 mg/1 + 2 more ingredients tablet, film coated, listed with the FDA by Alembic Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: carbidopa, levodopa and entacapone.
What is the active ingredient?: Carbidopa, Levodopa, Entacapone.
Who is the labeler?: Alembic Pharmaceuticals Inc., NDC labeler code 62332. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for carbidopa, levodopa and entacapone?: 29 other product NDCs are listed under this name. See all carbidopa, levodopa and entacapone NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other carbidopa, levodopa and entacapone NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
carbidopa, levodopa and entacapone	Carbidopa 12.5 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-795	46708-0795-3146708-0795-91
carbidopa, levodopa and entacapone	Carbidopa 18.75 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-796	46708-0796-3146708-0796-91
carbidopa, levodopa and entacapone	Carbidopa 25 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-797	46708-0797-3146708-0797-91
carbidopa, levodopa and entacapone	Carbidopa 31.25 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-798	46708-0798-3146708-0798-91
carbidopa, levodopa and entacapone	Carbidopa 37.5 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-799	46708-0799-3146708-0799-91
carbidopa, levodopa and entacapone	Carbidopa 50 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-800	46708-0800-3146708-0800-91
carbidopa, levodopa and entacapone	Carbidopa 12.5 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-795	62332-0795-3162332-0795-91
carbidopa, levodopa and entacapone	Carbidopa 18.75 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-796	62332-0796-3162332-0796-91
carbidopa, levodopa and entacapone	Carbidopa 25 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-797	62332-0797-3162332-0797-91
carbidopa, levodopa and entacapone	Carbidopa 31.25 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-798	62332-0798-3162332-0798-91

All 30 carbidopa, levodopa and entacapone NDCs

Other NDCs under ANDA 218535

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218535
Product	Strength	Form · route	Labeler	Product NDC
carbidopa, levodopa and entacapone	Carbidopa 12.5 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-795
carbidopa, levodopa and entacapone	Carbidopa 37.5 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-799
carbidopa, levodopa and entacapone	Carbidopa 18.75 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-796
carbidopa, levodopa and entacapone	Carbidopa 25 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-797
carbidopa, levodopa and entacapone	Carbidopa 31.25 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-798
carbidopa, levodopa and entacapone	Carbidopa 50 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-800
carbidopa, levodopa and entacapone	Carbidopa 18.75 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-796
carbidopa, levodopa and entacapone	Carbidopa 12.5 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-795
carbidopa, levodopa and entacapone	Carbidopa 50 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-800
carbidopa, levodopa and entacapone	Carbidopa 25 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-797
carbidopa, levodopa and entacapone	Carbidopa 31.25 mg/1 + 2 more ingredients	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-798